Table 3.

Relation between pSTAT1 versus markers of genomic instability and clinicopathological characteristics among the study cohort.

pSTAT1		Univariate			Multivariate
		Beta	95% CI	P value	Beta	95% CI	P value
Tumor subtypes	ER+/HER2-	Ref.			Ref.
	HER2+	0.125	2.085–19.001	0.015	0.046	−5.278–12.442	0.427
	TNBC	0.420	28.602–46.639	<0.0001	0.134	−2.400–26.212	0.103
Tumor grade	I	Ref.			Ref.
	II	0.106	−2.024–19.093	0.113	0.084	−3.607–16.195	0.212
	III	0.339	15.832–35.847	<0.0001	0.165	0.769–22.728	0.036
Tumor Stage	I	Ref.
	II	−0.036	−11.232–5.566	0.508
	III	0.043	−7.333–17.302	0.427
γH2AX		0.369	0.401–0.687	<0.0001	0.221	0.157–0.495	<0.0001
pRPA		0.167	0.053–0.218	0.001	0.151	0.035–0.201	0.006
Cyclin E1(n)		0.264	0.140–0.313	<0.0001	0.067	−0.064–0.180	0.351
Cyclin E1(c)		0.170	0.054–0.218	0.001	−0.089	−0.175–0.039	0.214
c-Myc		0.260	0.172–0.392	<0.0001	0.139	0.020–0.273	0.023

P values in bold indicate P < 0.05.